Skip to main content

Advertisement

SpringerLink
Log in

Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Lung cancer is the leading cause of cancer-related mortality world-wide. Since the majority of cancer deaths result from metastatic complications, understanding cellular alterations contributing to organ specific metastases is a continuing cancer research goal. Desirable models involve easy, efficient methodologies for development of pulmonary metastases utilizing genetically related syngeneic tumor cell lines varying in clonogenic frequency and growth rate for comparative studies. This work focused on development and characterization of primary and metastatic Lewis lung subclones (LLCC3, LLC1, LLCab) in a histocompatible C57Bl/6 model. Surgical resection of primary tumors utilizing these cell lines resulted in reliable development of pulmonary metastases (> 90% of injected mice), while tail-vein injection proved sporadic (20% of injected mice). The preliminary analysis of selected cell-surface molecules indicates potential genetic differences that may underlie phenotypic variations. The combination of subcutaneous resection methodology and variant cell lines results in robust metastatic lung cancer for testing potential therapeutic interventions.

Abbreviations: DFMO – difluoromethylornithine; EDTA – ethylenediaminetetraacetic acid; LLC – Lewis lung cell; MHC – major histocompatibility complex; NK – natural killer cell; VCAM – vascular cell adhesion molecule; VLA-4 – very late antigen-4 (VLA-4)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coleman WB, Tsongalis GJ. The Molecular Basis of Human Cancer. Totowa, New Jersey: Humana Press 2002; 3–22.

    Google Scholar 

  2. Maniwa Y, Okada M, Ishii N, Kiyooka. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest 1998; 114: 1668–75.

    PubMed  CAS  Google Scholar 

  3. Goto H, Yano S, Zhang H et al. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinomas in nude mice. Cancer Res 2002; 62 (13): 3711–5.

    PubMed  CAS  Google Scholar 

  4. Shindo-Okada N, Takeuchi K, Han BS, Nagamachi Y. Establishment of cell lines with high and low metastatic potential from A549 human lung adenocarcinoma. Jpn J Cancer Res 2002; 93 (1): 50–60.

    PubMed  CAS  Google Scholar 

  5. Wildbrett P, Oh A, Carter JJ et al. Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc 2002; 16 (8): 1162–9.

    Article  PubMed  CAS  Google Scholar 

  6. Cheng WF, Hung CF, Lin KY et al. CD8+ T cells, NK cells and IFNgamma are important for control of tumor with down-regulated MHC class I expression by DNA vaccination. Gene Ther 2003; 10 (16): 1311–20.

    Article  PubMed  CAS  Google Scholar 

  7. Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003; 195 (3): 346–55.

    Article  PubMed  CAS  Google Scholar 

  8. Ibrahim el C, Allory Y, Commo F et al. Altered pattern of major histocompatibility complex expression in renal carcinoma: Tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol 2003; 162 (2): 501–8.

    PubMed  Google Scholar 

  9. Cruet-Hennequart S, Maubant S, Luis J et al. Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Onogene 2003; 22 (11): 1688–702.

    Article  CAS  Google Scholar 

  10. Takaoka K, Sakurai K, Noguchi K et al. Endovascular papillary angioendothelioma (Dabska tumor) of the tongue: Report of a case. J Oral Pathol Med 2003; 32 (8): 492–5.

    Article  PubMed  Google Scholar 

  11. Gaenko GP, Kozlov AM, Saprykina NS et al. Phenotypic characteristics of Lewis lung carcinoma cells. Bull Exp Biol Med 2002; 134 (4): 382–4.

    Article  PubMed  CAS  Google Scholar 

  12. Fuster MM, Brown JR, Wang L, Esko JD. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res 2003; 63 (11): 2775–81.

    PubMed  CAS  Google Scholar 

  13. Lobb R, Hemler M. The pathophysiologic role of alpha4 integrins in vivo. J Clin Invest 1994; 94 (5): 1722–8.

    Article  PubMed  CAS  Google Scholar 

  14. Tozawa K, Kawai N, Hayashi Y et al. Gold compounds inhibit adhesion of human cancer cells to vascular endothelial cells. Cancer Lett 2003; 196 (1): 93–100.

    Article  PubMed  CAS  Google Scholar 

  15. Young MR, Newby M, Meunier J. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma. Cancer Res 1985; 45: 3918–23.

    PubMed  CAS  Google Scholar 

  16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.

    Article  PubMed  CAS  Google Scholar 

  17. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148–54.

    Article  PubMed  CAS  Google Scholar 

  18. Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas–an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20–3.

    Article  PubMed  CAS  Google Scholar 

  19. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1 (2): 149–53.

    Article  PubMed  CAS  Google Scholar 

  20. O'Reilly MS et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277–85.

    Article  PubMed  Google Scholar 

  21. Hatakawa H, Funakoshi N, Onizuka M et al. Blood flow does not correlate with the size of metastasis in our new intravital observation model of Lewis lung cancer. Microvasc Res 2002; 64 (1):32–7.

    Article  PubMed  Google Scholar 

  22. O'Reilly MS et al. Angiostatin: A Novel Angiogenesis Inhibitor that Mediates the Suppression of Metastases by a Lewis Lung Carcinoma. Cell 1994; 79: 315–328.

    Article  PubMed  Google Scholar 

  23. Jothy S. CD44 and its partners in metastasis. Clin Exp Metast 2003; 20: 195–201.

    Article  CAS  Google Scholar 

  24. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metast 2003; 20: 203–13.

    Article  CAS  Google Scholar 

  25. Thurin M, Kieber-Emmons T. SA-Lea and tumor metastasis: The old prediction and recent findings. Hybrid Hybridomics 2002; 21 (2): 111–6.

    Article  PubMed  CAS  Google Scholar 

  26. Palumbo JS, Degen JL. Fibrinogen and tumor metastasis. Haemostasis 2001; 31 (Suppl 1): 11–5.

    PubMed  CAS  Google Scholar 

  27. Gaenko GP, Kozlov AM, Saprykina NS et al. Phenotypic characteristics of Lewis lung carcinoma cells. Bull Exp Biol Med 2002; 134 (4): 382–4.

    Article  PubMed  CAS  Google Scholar 

  28. Kanwar J, Berg R, Lehnert K, Krissansen G. Taking lessons from dendritic cells: Multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity. Gene Ther 1999; 6 (11): 1835–44.

    Article  PubMed  CAS  Google Scholar 

  29. Orntoft TF, Vestergaard EM. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999; 20: 362–71.

    Article  PubMed  CAS  Google Scholar 

  30. Eisenbach L, Segal S, Feldman M. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int J Cancer 1983; 32 (1): 113–20.

    PubMed  CAS  Google Scholar 

  31. Kiger N. Heterogeneity in surface antigen of cell lines and clones from a murine carcinoma. Int J Cancer 1985; 35 (1): 129–34.

    PubMed  CAS  Google Scholar 

  32. Juul-Madsen HR, Olsson L. Discrepancy between transcriptional products and cell surface expression of MHC class I antigens in metastatic and non-metastatic Lewis lung tumor cells. APMIS 1990; 98 (7): 624–36.

    Article  PubMed  CAS  Google Scholar 

  33. Bakker ABH, Phillips JH, Figdor CG, Lanier LL. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, ? dT cells, and antigen-specific CTL. J Immunol 1998; 160: 5239–45.

    PubMed  CAS  Google Scholar 

  34. Guerra N, Michel F, Gati A et al. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 2002; 100 (8): 2874–81.

    Article  PubMed  CAS  Google Scholar 

  35. Warren HS, Christiansen FT, Witt CS. Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis. Br J Haematol 2003; 121 (5): 793–804.

    Article  PubMed  CAS  Google Scholar 

  36. Bai XF, Liu J, Li O et al. Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. J Clin Invest 2003; 111 (10): 1487–96.

    Article  PubMed  CAS  Google Scholar 

  37. Lanier LL. Natural killer cells: From no receptors to too many. Immunity 1997; 6: 371–88.

    Article  PubMed  CAS  Google Scholar 

  38. Youn B, Mantel C, Broxmeyer HE. Chemokines, chemokine receptors and hematopoiesis. Immunol Rev 2000; 177: 150–74.

    Article  PubMed  CAS  Google Scholar 

  39. Moore M. The role of chemoattraction in cancer metastases. BioEssays 2001; 23: 674–6.

    Article  PubMed  CAS  Google Scholar 

  40. Young MR, Kolesiak K, Wright MA, Gabrilovich DI. Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clin Exp Metast 1999; 17 (10): 881–8.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Bill T. Storey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph F. Christian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Storey, B.T., Christian, J.F. Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases. Clin Exp Metastasis 21, 265–273 (2004). https://doi.org/10.1023/B:CLIN.0000037728.44457.13

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CLIN.0000037728.44457.13

Search

Navigation